{"id":"W1994649501","doi":"10.1002/art.27601","title":"The efficacy and safety of abatacept in patients with non–life‐threatening manifestations of systemic lupus erythematosus: Results of a twelve‐month, multicenter, exploratory, phase IIb, randomized, double‐blind, placebo‐controlled trial","year":2010,"lang":"en","type":"article","venue":"Arthritis & Rheumatism","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":375,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"UCB Pharma; Bristol-Myers Squibb","keywords":"Medicine; Abatacept; Placebo; Internal medicine; Randomized controlled trial; Polyarthritis; Surgery; Arthritis; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003550505,0.0003844177,0.002480504,0.0004372867,0.0001667271,0.0000380327,0.000277487,0.0001929786,0.00002586595],"category_scores_gemma":[0.002665536,0.0002508075,0.0002375644,0.0003740416,0.0007649352,0.0002680307,0.0001095904,0.0004633119,0.000004918933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000492369,"about_ca_system_score_gemma":0.0003466641,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003999956,"about_ca_topic_score_gemma":0.0007102496,"domain_scores_codex":[0.9943234,0.000561359,0.003075172,0.0004846343,0.001062768,0.0004926526],"domain_scores_gemma":[0.9925376,0.003969535,0.001648001,0.00088351,0.0007094347,0.0002519144],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9721823,0.001280371,0.008253577,0.0006748372,0.0005849794,0.00002897538,0.01374147,0.0000233927,0.0005365715,0.000197528,0.00005402229,0.002441957],"study_design_scores_gemma":[0.9810817,0.001358879,0.0002214075,0.0110158,0.0001887894,0.0007463187,0.004047989,0.0008838887,0.0002331223,0.00002081909,0.000003826694,0.0001974359],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9806886,0.002471887,0.0001242422,0.00008309219,0.0005058042,0.0157105,0.0001059668,0.00003075881,0.0002791861],"genre_scores_gemma":[0.9956851,0.002531417,0.0004491009,0.000003915122,0.00003594306,0.001074581,0.0000661665,0.00006182231,0.00009194811],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01499654,"threshold_uncertainty_score":0.9999944,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.014021235672382,"score_gpt":0.2806700027418059,"score_spread":0.2666487670694239,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}